Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): A 56-week, open-label, randomized clinical trial
Frias JP, Nauck MA, Van J, et al
Faubion is just finishing up a study of 160 pre-, peri-, and postmenopausal women on GLP-1ssome of whom are also on MHTand hopes to have the results available by the fall
Prescription GLP-1 medications like semaglutide and tirzepatide are commonly used for diabetes and weight loss
Moreover, GLP-1RAs can reverse EndMT induced by high glucose and IL-1 via activating the AMPK pathway, which was evidenced by augmenting an endothelium marker expression (CD31), as well as alleviating mesenchymal markers expression (SM22 (sensitive 22 kDa actin-binding protein of the calponin), vimentin and Snail) [119]